Results 31 to 40 of about 35,407 (190)

Local treatment failure after globe-conserving therapy for choroidal melanoma. [PDF]

, 2013
Local treatment failure after globe-conserving therapy for choroidal melanoma is a surgical complication with significant morbidity to the vision and eye. Few reports in the literature have addressed this complication exclusively.
Chang, Melinda Y, McCannel, Tara A
core   +1 more source

Differences and Similarities in Epidemiology and Risk Factors for Cutaneous and Uveal Melanoma

Medicina, 2023
Both cutaneous melanoma (CM) and uveal melanoma (UM) represent important causes of morbidity and mortality. In this review, we evaluate the available knowledge on the differences and similarities between cutaneous melanoma and uveal melanoma, focusing on
Daciana Elena Brănișteanu, Elena Porumb-Andrese, Alexandra Stărică, Anca Catalina Munteanu, Mihaela Paula Toader, Mihail Zemba, Vlad Porumb, Mihai Cozmin, Andreea Dana Moraru, Alin Codruț Nicolescu, Daniel Constantin Brănișteanu   +10 more
doaj   +1 more source

The reporting of uveal melanoma cases to the cancer registry in North Carolina

Frontiers in Oncology, 2022
ObjectiveTo ascertain the completeness of reporting of uveal melanoma cases in North Carolina to the state’s cancer registry.MethodsThis was a retrospective chart review performed at a single institution analyzing the completeness of information reported
Kathleen G. Gordon, Richard D. Carvajal, Sharnee’ L. Graham, Odette M. Houghton   +3 more
doaj   +1 more source

Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients [PDF]

, 2014
Purpose: To assess the safety and efficacy of dendritic cell vaccination in metastatic uveal melanoma. Design: Interventional case series. Methods: We analyzed 14 patients with metastatic uveal melanoma treated with dendritic cell vaccination.
Aarntzen, E.H.J.G. (Erik), Bol, K.F. (Kalijn), Coulie, P.G. (Pierre), Figdor, C.G. (Carl), Keunen, J.E.E. (Jan), Klein, J.E.M.M. (Annelies) de, Mensink, H.W. (Hanneke), Paridaens, A.D.A. (Dion), Punt, C.J.A. (Cornelis), Schreibelt, G. (Gerty), Vries, I.J.M. (Jolanda) de   +10 more
core   +1 more source

Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment. [PDF]

, 2017
CXCR1 and CXCR2 chemokine receptors and their ligands (CXCL1/2/3/7/8) play an important role in tumor progression. Tested to date CXCR1/2 antagonists and chemokine-targeted antibodies were reported to affect malignant cells in vitro and in animal models.
Alexeev, Vitali, Allegretti, Marcello, De Pizzol, Maria, Igoucheva, Olga, Jonas, Rebecca, Kemp, Daria Marley, Larijani, Mary, Lash, Elizabeth, Pidich, Alyson, Sato, Takami, Terai, Mizue   +10 more
core   +2 more sources

Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study [PDF]

, 2014
BACKGROUND: To examine the all-cause mortality and uveal melanoma specific mortality among newly diagnosed uveal melanoma patients after five years. Furthermore, we assess of the effect of iris colour and having children on 5-year risk of death after ...
Andrea Schmidt-Pokrzywniak, Andreas Stang, Karl-Heinz Jöckel, Norbert Bornfeld, Oliver Kuss, Sven Kalbitz   +5 more
core   +2 more sources

Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part I: MR imaging with pathologic correlation and technical considerations

Insights into Imaging, 2021
Uveal melanoma is a malignant neoplasm that derives from pigmented melanocytes of the uvea and involves, in order of decreasing prevalence, the choroid, ciliary body and iris.
Pietro Valerio Foti, Mario Travali, Renato Farina, Stefano Palmucci, Corrado Spatola, Luigi Raffaele, Vincenzo Salamone, Rosario Caltabiano, Giuseppe Broggi, Lidia Puzzo, Andrea Russo, Michele Reibaldi, Antonio Longo, Paolo Vigneri, Teresio Avitabile, Giovani Carlo Ettorre, Antonio Basile   +16 more
doaj   +1 more source

Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma. [PDF]

, 2015
Uveal melanoma patients with metastatic disease usually die within one year, emphasizing an urgent need to develop new treatment strategies for this cancer.
Aplin, Andrew E., Cheng, Hanyin, Kageyama, Ken, McCue, Peter, Ozaki, Shinji, Sato, Takami, Terai, Mizue   +6 more
core   +2 more sources

Immunohistochemical Expression of ABCB5 as a Potential Prognostic Factor in Uveal Melanoma

Applied Sciences, 2019
Uveal melanoma represents the most common primary intraocular malignancy in adults; it may arise in any part of the uveal tract, with choroid and ciliary bodies being the most frequent sites of disease.
Giuseppe Broggi, Giuseppe Musumeci, Lidia Puzzo, Andrea Russo, Michele Reibaldi, Marco Ragusa, Antonio Longo, Rosario Caltabiano   +7 more
doaj   +1 more source

Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma

American Journal of Ophthalmology Case Reports, 2021
Purpose: To describe two cases of medium-sized uveal melanoma presenting with hemorrhagic choroidal detachments. Observations: The first case is a 39-year-old man who presented with choroidal hemorrhage and angle closure glaucoma. The second case is a 42-
Yewlin E. Chee, Raghu Mudumbai, Steven S. Saraf, Thellea Leveque, Verena S. Grieco, Monique A. Mogensen, Rebecca A. Yoda, Luis F. Gonzalez-Cuyar, Andrew W. Stacey   +8 more
doaj   +1 more source